Methylprednisolone covid study

Mar 26, 2022 · Our study showed that methylprednisolone therapy within 1 week could benefit patients with COVID-19, which is close to the treatment course (3–5 days) recommended by the guideline from China. Methods: The study was a multicentric open-label trial of COVID-19 patients who were aged ≥ 18 years, receiving oxygen without mechanical ventilation, and with evidence of systemic inflammatory response who were assigned to standard of care (SOC) or SOC plus intravenous MP (40 mg bid for 3 days followed by 20 mg bid for 3 days)

2024-03-28
    Tamsulosin dose in dialysis patients
  1. Gov't Jun 17, 2022 · 10
  2. We designed a pragmatic, randomized trial
  3. 01) respectively
  4. A total of 102 severe and critically ill COVID-19 patients were
  5. More than 13
  6. Study design and patient population
  7. In a retrospective cohort study done by Wang et al